Visit for the latest Coronavirus Disease (COVID-19) updates.

You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 

Management of Multidrug-Resistant Organisms In Health Care Settings

Description of Resource: 
Multidrug-resistant organisms (MDROs), including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and certain gram-negative bacilli, have important infection control implications that either have not been addressed or received only limited consideration in previous isolation guidelines. Increasing experience with these organisms is improving understanding of the routes of transmission and effective preventive measures. The guideline provides recommendations for the implementation of strategies and practices to prevent the transmission of MRSA, VRE, and other MDROs.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
Centers for Disease Control and Prevention, Healthcare Infection Control Practices Advisory Committee
Developer Type: 
Federal Government
Healthy People 2020 Topic Area(s): 
Healthcare-Associated Infections
Healthy People 2020 Objectives: 
Resource Type: 
Systematic Review
Expert Opinion
Siegel J, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee. Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006 [Internet]. 2006 [cited 2013 Feb 28]. Available from: